Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Summary

Randomized phase II trial to compare the effectiveness of two regimens of rebeccamycin analogue in treating women who have stage IIIB or stage IV breast cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. The best way to give rebeccamycin analog in breast cancer patients is not yet known

Timeline

Start

2000-03

Primary completion

2006-05

Completion

—

Drugs

Indications